Insider plans 34,799-share Precision BioSciences (DTIL) sale in Rule 144 filing

Rhea-AI Filing Summary

Precision BioSciences plans an insider stock sale under Rule 144. A holder intends to sell 34,799 shares of DTIL common stock through Fidelity Brokerage Services LLC on or around 01/22/2026, with an indicated aggregate market value of $145,202.30. The shares are listed on the NASDAQ.

The securities to be sold were acquired on 01/20/2026 through restricted stock vesting from the issuer as compensation. The filing also notes that Michael Amoroso sold 3,409 common shares on 11/03/2025 for gross proceeds of $22,121.00. The signer represents that they are not aware of undisclosed material adverse information about the company’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	34799	145202.30	13256751	01/22/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/20/2026	Restricted Stock Vesting	Issuer			34799	01/20/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Amoroso 302 East Pettigrew St. Suite A-100 Durham NC 27701	Common	11/03/2025	3409	22121.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Precision BioSciences (DTIL) disclose in this Form 144 filing?

The filing indicates an intention to sell 34,799 shares of DTIL common stock under Rule 144, with an aggregate market value of $145,202.30, through Fidelity Brokerage Services LLC.

When and where are the DTIL shares in this Form 144 expected to be sold?

The approximate sale date is 01/22/2026, and the DTIL common shares are listed for trading on the NASDAQ exchange.

How were the DTIL shares in this Form 144 acquired?

The 34,799 DTIL common shares were acquired on 01/20/2026 via restricted stock vesting from the issuer, received as compensation.

Does the Form 144 for Precision BioSciences (DTIL) show any recent prior sales?

Yes. It reports that Michael Amoroso sold 3,409 DTIL common shares on 11/03/2025 for gross proceeds of $22,121.00.

What representation does the seller make in this DTIL Form 144 notice?

By signing the notice, the seller represents that they do not know of any material adverse information about Precision BioSciences’ current or prospective operations that has not been publicly disclosed.

Which broker is handling the planned DTIL share sale under this Form 144?

The planned sale of 34,799 DTIL common shares is to be handled by Fidelity Brokerage Services LLC, based in Smithfield, Rhode Island.